Chloe Delepine

7PUBLICATIONS

73CO-AUTHORS

Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisationPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 15, 2026

Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer.

|Apr 14, 2026

Early differential impact of MeCP2 mutations on functional networks in Rett syndrome patient-derived human cortical organoids.

Tatsuya Osaki, Chloe Delepine, Yuma Osako

|Jan 27, 2025

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Breelyn A Wilky, Gary K Schwartz, Michael S Gordon

|Jul 31, 2024

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

|Jun 13, 2024

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih

|Jul 29, 2022

Label-free three-photon imaging of intact human cerebral organoids for tracking early events in brain development and deficits in Rett syndrome.

Murat Yildirim, Chloe Delepine, Danielle Feldman

Pageof 2

Frequent Collaborators

Joseph E Grossman

Dhan Chand

Justin Stebbing

Vincent A Pham

Mriganka Sur

Andrea J Bullock

Murat Yildirim

Hans Binder

Li-Huei Tsai

Benjamin L Schlechter

Frequent Collaborators

Joseph E Grossman

Dhan Chand

Justin Stebbing

Vincent A Pham